Prudential Financial’s PMV Pharmaceuticals PMVP Stock Holding History

Prudential Financial’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33,360	Closed	-$209K	–	2677
2023 Q2	$209K	Buy	+33,360	New	+$175K	﹤0.01%	2428
2022 Q2	–	Sell	-50,825	Closed	-$1.06M	–	2734
2022 Q1	$1.06M	Hold	50,825	–	–	﹤0.01%	1845
2021 Q4	$1.2M	Sell	50,825 -1,043	-2%	-$25.2K	﹤0.01%	1798
2021 Q3	$1.54M	Buy	51,868 +17,950	+53%	+$573K	﹤0.01%	1580
2021 Q2	$1.16M	Buy	33,918 +1,703	+5%	+$56.9K	﹤0.01%	1767
2021 Q1	$1.06M	Buy	+32,215	New	+$1.27M	﹤0.01%	1788

Other funds holding PMVP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prudential Financial's PMVP Position: Q3 2023 in Review

Prudential Financial sold out of PMV Pharmaceuticals (PMVP) in Q3 2023, closing a stake of 33,360 shares — an estimated $209K sold.

Prudential Financial first reported a position in PMVP in Q1 2021 and held it in 6 quarters. The position peaked at $1.54M in Q3 2021. 104 funds tracked by Wall St. Rank hold PMVP as of Q3 2023.

Prudential Financial reported no remaining PMV Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Prudential Financial sold 33,360 PMV Pharmaceuticals shares in Q3 2023, an estimated $209K.
Prudential Financial first reported a position in PMV Pharmaceuticals in Q1 2021 and held it in 6 quarters.
Prudential Financial's PMV Pharmaceuticals position peaked at $1.54M in Q3 2021.
104 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2023.

Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.